Advance Clinical Update in Oncology Course Films NOW AVAILABLE

BOPA E&T is delighted to announce that the films of the Advance Clinical Update in Oncology Course held at the Royal Marsden earlier this year are now live and available on the BOPA website. Check them out for updates in Breast, GI and Lung cancer provided by leading clinicians at the Trust. For those of you interested in haemato-oncology, we have updates in Myeloma and relapsed refractory ALL. You can also hear about the amazing collaborative work being done in a pharmacist and nurse led immunotherapy clinic.  Check out the Biosimilars in Oncology session to learn from the experiences of the Marsden during their introduction of biosimilar Trastuzumab and about the Cancer Vanguard biosimilar Rituximab project. 

Bryn Thomas, 
E&T BOPA Sub Committee Chair
 

Latest News

By BOPA Research Committee on 25th April 2024

Survey: Pharmacogenomic Panel Testing in Cancer: UK Oncology Professionals

Please consider completing our BOPA member survey on the use of pharmacogenomic panel testing in people with solid tumours. Survey information I’m a pharmacist and pre-doctoral research fellow researching the…

Read article
By BOPA Research committee on 25th April 2024

NIHR Associate Principal Investigator (PI) Scheme is continuing to host Research Learning Lectures

The NIHR Associate Principal Investigator (PI) Scheme is continuing to host the Research Learning Lectures; a series of lectures for anyone in Health and Social Care interested in learning more about research.…

Read article
By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article